in patients suffering from chronic pancreatitis ( outside exacerbation ) with initial enzyme-secretory pancreatic failure , the two-week intake of pancreatin as a replacement therapy brought about a decrease of the enzyme-secretory activity of the patient 's own pancreas paralleled by the lowering of diurnal steatorrhea .
C0149521
chronic pancreatitis
C0030274
pancreas